Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Methylene blue MMX® tablets for chromoendoscopy. Bioavailability, colon staining and safety in healthy volunteers undergoing a full colonoscopy.

Di Stefano AFD, Radicioni MM, Vaccani A, Fransioli A, Longo L, Moro L, Repici A.

Contemp Clin Trials. 2018 Aug;71:96-102. doi: 10.1016/j.cct.2018.06.001. Epub 2018 Jun 2.

2.

An exploratory microdialysis study investigating the effect of repeated application of a diclofenac epolamine medicated plaster on prostaglandin concentrations in skeletal muscle after standardized physical exercise.

Burian A, Frangione V, Rovati S, Mautone G, Leuratti C, Vaccani A, Crevenna R, Keilani M, Burian B, Brunner M, Zeitlinger M.

Br J Clin Pharmacol. 2013 Dec;76(6):880-7. doi: 10.1111/bcp.12125.

3.

5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.

Massi P, Valenti M, Vaccani A, Gasperi V, Perletti G, Marras E, Fezza F, Maccarrone M, Parolaro D.

J Neurochem. 2008 Feb;104(4):1091-100. Epub 2007 Nov 17.

4.

Cannabinoids, immune system and cytokine network.

Massi P, Vaccani A, Parolaro D.

Curr Pharm Des. 2006;12(24):3135-46. Review.

PMID:
16918439
5.

The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells.

Massi P, Vaccani A, Bianchessi S, Costa B, Macchi P, Parolaro D.

Cell Mol Life Sci. 2006 Sep;63(17):2057-66.

PMID:
16909207
6.

Dendritic localization of the translational repressor Pumilio 2 and its contribution to dendritic stress granules.

Vessey JP, Vaccani A, Xie Y, Dahm R, Karra D, Kiebler MA, Macchi P.

J Neurosci. 2006 Jun 14;26(24):6496-508.

7.

Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.

Viganò D, Rubino T, Vaccani A, Bianchessi S, Marmorato P, Castiglioni C, Parolaro D.

Psychopharmacology (Berl). 2005 Nov;182(4):527-36. Epub 2005 Oct 19.

PMID:
16079992
8.

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism.

Vaccani A, Massi P, Colombo A, Rubino T, Parolaro D.

Br J Pharmacol. 2005 Apr;144(8):1032-6.

9.

The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro.

Sacerdote P, Martucci C, Vaccani A, Bariselli F, Panerai AE, Colombo A, Parolaro D, Massi P.

J Neuroimmunol. 2005 Feb;159(1-2):97-105. Epub 2004 Dec 1.

PMID:
15652407
10.

Cannabinoids and opioids share cAMP pathway in rat splenocytes.

Massi P, Vaccani A, Rubino T, Parolaro D.

J Neuroimmunol. 2003 Dec;145(1-2):46-54.

PMID:
14644030
11.

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.

Massi P, Vaccani A, Ceruti S, Colombo A, Abbracchio MP, Parolaro D.

J Pharmacol Exp Ther. 2004 Mar;308(3):838-45. Epub 2003 Nov 14.

12.

Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain.

Viganò D, Grazia Cascio M, Rubino T, Fezza F, Vaccani A, Di Marzo V, Parolaro D.

Neuropsychopharmacology. 2003 Jun;28(6):1160-7. Epub 2003 Mar 12.

13.

Supplemental Content

Loading ...
Support Center